Ubrogepant for acute migraine relief in kids and teens
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests how safe ubrogepant is and whether it helps treat an individual migraine attack in children and teens. It focuses on measuring side effects and whether headaches improve 2 hours after taking the study medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have migraine headaches (with or without aura) for at least 6 months
- Your migraines usually last 3 to 72 hours when not treated, with at least 48 hours between attacks
- In the last 2 months, you had 1 to 14 migraine attacks per month, with moderate-to-severe pain each time
- You take (or have taken) a medicine by mouth to treat migraine attacks
- You weigh at least 44 pounds (20 kg) but under 298 pounds (135 kg)
- You can swallow the study tablets and complete headache logs and questionnaires (with help if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows kids and teens who already took part in an earlier migraine medication study to check long-term safety and comfort with oral ubrogepant tablets. It may help families understand whether this migraine tablet is safe to keep using over time.
This study looks at how well the migraine medication ubrogepant works when taken during the early signs of a migraine (prodrome). It may help people who already use ubrogepant for their migraines.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This trial tests two new migraine medicines, rimegepant and zavegepant, given to people in the emergency department to see how well they work for stopping a migraine headache quickly.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.